The company remains focused on acquiring a business primarily in North America or Europe with strong growth prospects and recurring revenue. The company's NYSE American listing was removed after it failed to complete a business combination within the required timeframe, and its units, Class A shares and warrants now trade on the OTC Basic Market with a trust account reduced to about $1.0 million, leaving limited cash to fund a transaction before the December 4, 2026 deadline.
Cyborg Score Rationale
The SPAC faces critical execution risk with a liquidation deadline of December 4, 2026 (approximately 5.5 months away). Heavy shareholder redemptions have depleted the trust account to ~$1M, severely constraining acquisition targets. Delisting from NYSE American to OTC markets further reduces institutional credibility and liquidity.
Top Insights
Trust account depleted to approximately $1.0 million as of December 31, 2025 due to three extension votes and substantial shareholder redemptions
Suspended pursuit of hospitality business combination with Starwood Capital Group (November 2024) after flagship 1 Hotel Central Park deal fell through
Delisted from NYSE American and now trades OTC, reducing institutional investor appeal and liquidity
December 4, 2026 liquidation deadline imposes urgent timeline to identify and close a target or face mandatory return of remaining trust funds to public shareholders